Colgate Palmolive (CL) Common Equity (2016 - 2025)
Historic Common Equity for Colgate Palmolive (CL) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.
- Colgate Palmolive's Common Equity rose 4808.61% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 4808.61%. This contributed to the annual value of $544.0 million for FY2024, which is 4315.57% down from last year.
- Colgate Palmolive's Common Equity amounted to $1.2 billion in Q3 2025, which was up 4808.61% from $1.1 billion recorded in Q2 2025.
- Colgate Palmolive's 5-year Common Equity high stood at $24.4 billion for Q4 2021, and its period low was -$25.1 billion during Q4 2022.
- Its 5-year average for Common Equity is $616.7 million, with a median of $728.0 million in 2022.
- Its Common Equity has fluctuated over the past 5 years, first crashed by 20319.51% in 2022, then skyrocketed by 11825.73% in 2025.
- Quarter analysis of 5 years shows Colgate Palmolive's Common Equity stood at $24.4 billion in 2021, then crashed by 203.2% to -$25.1 billion in 2022, then surged by 103.81% to $957.0 million in 2023, then tumbled by 43.16% to $544.0 million in 2024, then surged by 127.57% to $1.2 billion in 2025.
- Its last three reported values are $1.2 billion in Q3 2025, $1.1 billion for Q2 2025, and $733.0 million during Q1 2025.